Paper9851965
Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo.
McEwan PE and 4 others. Circulation, 1998. Cited by 134 papers, by iCite.
Cite this record
ConductScience Library. Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo. Papers, record 9851965. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9851965
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angiotensin II | Major topic |
| Coronary Vessels | Major topic |
| Myocardium | Major topic |
| Aldosterone | |
| Animals | |
| Arterioles | |
| Blood Pressure | |
| Cell Division | |
| Collagen | |
| Endothelium, Vascular | |
| Fibrosis | |
| Losartan | |
| Male | |
| Rats | |
| Rats, Wistar | |
| Receptor, Angiotensin, Type 1 | |
| Receptor, Angiotensin, Type 2 | |
| Receptors, Angiotensin | |
| Renin |
Source PubMed
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 134 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40806350 | Cardioprotective Role of Captopril: From Basic to Applied Investigations. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806350 | PubMed |
| 38188450 | New-onset atrial fibrillation among COVID-19 patients: A narrative review. | World J Crit Care Med | 2023 | https://conductscience.org/library/papers/38188450 | PubMed |
| 37854465 | Role of monocytes/macrophages in renin-angiotensin system-induced hypertension and end organ damage. | Front Physiol | 2023 | https://conductscience.org/library/papers/37854465 | PubMed |
| 36941996 | Negative Troponin I as a Predictor of Survival in Patients With Coronavirus Disease 2019. | Int J Cardiol Heart Vasc | 2023 | https://conductscience.org/library/papers/36941996 | PubMed |
| 33850920 | Narrative review: the holy grail: update on pharmacotherapy for heart failure with preserved ejection fraction. | Ann Transl Med | 2021 | https://conductscience.org/library/papers/33850920 | PubMed |
| 32217149 | Anti-arrhythmic properties of non-antiarrhythmic medications. | Pharmacol Res | 2020 | https://conductscience.org/library/papers/32217149 | PubMed |
| 29885051 | Monocytes as immune targets in arterial hypertension. | Br J Pharmacol | 2019 | https://conductscience.org/library/papers/29885051 | PubMed |
| 28032630 | Preventive effect of renin-angiotensin system inhibitors on new-onset atrial fibrillation in hypertensive patients: a propensity score matching analysis. | J Hum Hypertens | 2017 | https://conductscience.org/library/papers/28032630 | PubMed |
| 27536429 | The role of the renin-angiotensin system blocking in the management of atrial fibrillation. | J Drug Assess | 2012 | https://conductscience.org/library/papers/27536429 | PubMed |
| 27340270 | The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. | Circ Res | 2016 | https://conductscience.org/library/papers/27340270 | PubMed |
| 26133668 | The angiotensin receptor blocker losartan reduces coronary arteriole remodeling in type 2 diabetic mice. | Vascul Pharmacol | 2016 | https://conductscience.org/library/papers/26133668 | PubMed |
| 25682436 | Effect of angiotensin-converting enzyme inhibitors and receptor blockers on appropriate implantable cardiac defibrillator shock in patients with severe systolic heart failure (from the GRADE Multicenter Study). | Am J Cardiol | 2015 | https://conductscience.org/library/papers/25682436 | PubMed |
| 24150005 | Angiotensin-converting enzyme genotype affects skeletal muscle strength in elite athletes. | J Sports Sci Med | 2009 | https://conductscience.org/library/papers/24150005 | PubMed |
| 22522403 | Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hypertensive patients with normal or increased left atrial size. | Clin Cardiol | 2012 | https://conductscience.org/library/papers/22522403 | PubMed |
| 22400124 | Genomic research to identify novel pathways in the development of abdominal aortic aneurysm. | Cardiol Res Pract | 2012 | https://conductscience.org/library/papers/22400124 | PubMed |
| 21626163 | Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. | Heart Fail Rev | 2012 | https://conductscience.org/library/papers/21626163 | PubMed |
| 21572015 | CCR2 mediates the uptake of bone marrow-derived fibroblast precursors in angiotensin II-induced cardiac fibrosis. | Am J Physiol Heart Circ Physiol | 2011 | https://conductscience.org/library/papers/21572015 | PubMed |
| 20719940 | Histone deacetylase: a potential therapeutic target for fibrotic disorders. | J Pharmacol Exp Ther | 2010 | https://conductscience.org/library/papers/20719940 | PubMed |
| 20216089 | High-salt diet during pregnancy and angiotensin-related cardiac changes. | J Hypertens | 2010 | https://conductscience.org/library/papers/20216089 | PubMed |
| 19863867 | Hypertension and atrial fibrillation. | Curr Cardiol Rep | 2009 | https://conductscience.org/library/papers/19863867 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9851965
GET https://conductscience.org/api/papers/v1/9851965/cited_by?page=2